Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8604184 Chemically programmable immunity
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 2 Oct, 2024
"update inverses"
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 28 Aug, 2024
"update inverses"
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12064483 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
0
Edits on 12 Jun, 2024
"update inverses"
Golden AI
edited on 12 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12006499 Una amidites and uses thereof
0
Edits on 6 Jun, 2024
"update inverses"
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Edits on 19 Jan, 2024
"update inverses"
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof
0
Edits on 2 Aug, 2023
"update inverses"
Golden AI
edited on 2 Aug, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
Edits on 26 Jul, 2023
"update inverses"
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11707532 Compositions and methods of treating muscle dystrophy
0
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox
(
+1
/
-1
properties)
US Patent 08604184 Chemically programmable immunity
US Patent 8604184 Chemically programmable immunity
Infobox
Patent Number
08604184
0
Patent Number
8604184
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
08604184
0
Date of Patent
December 10, 2013
0
Patent Application Number
12774194
0
Date Filed
May 5, 2010
0
Patent Primary Examiner
Albert Navarro
0
Edits on 21 Dec, 2021
"Created via: Entity Importer"
Golden AI
created this topic on 21 Dec, 2021
Edits made to:
Infobox
(
+7
properties)
US Patent 08604184 Chemically programmable immunity
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
08604184
Date of patent
December 10, 2013
Patent application number
12774194
Date Filed
May 5, 2010
Patent primary examiner
Albert Navarro
Find more entities like US Patent 8604184 Chemically programmable immunity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE